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syndrome: related to food hypersensitivities
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Abstract 
Patients with Sjogren’s syndrome (SS) frequently have irritable bowel like symptoms (IBS). Some have celiac sprue. The 
current studies were designed to examine the presence of food hypersensitivities in a population of patients with 
SS and IBS. Ten patients were selected from the autoimmune disease clinics at SUNY at Buffalo who had SS and IBS 
symptoms. Food hypersensitivities were determined by specific IgG ImmunoCAP® assays. Symptoms of abdominal 
pain, bloating, diarrhea and joint pain were eliminated with dietary restriction of foods to which hypersensitivity was 
demonstrated. Symptoms recurred with re‑institution of offending foods. Resolution of fatigue required elimination of 
offending foods as well as treatment of underlying metabolic disorders. The presence of IBS in patients with SS should 
lead to investigation of food hypersensitivities as possible culprits.
© 2015 Kim‑Lee et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made.
Background
Sjogren’s syndrome (SS) is a common autoimmune dis-
ease characterized by destruction of the salivary and 
lacrimal glands leading to symptoms of dry eyes and 
dry mouth. Extra-glandular manifestations commonly 
include lung disease, kidney disease and lymphoma 
(Delaleu et  al. 2005; Mavragani and Moutsopoulos 
2014). Lymphomas may occur in the salivary glands but 
also frequently in the gastrointestinal tract (Liang et  al. 
2014; Mariette 1999). Gastrointestinal disease in SS may 
occur in one quarter of the patients and include dyspha-
gia, gastritis, motility disorders, pancreatitis, pancreatic 
insufficiency, pernicious anemia, autoimmune hepatitis 
and symptoms consistent with irritable bowel syndrome 
(IBS), abdominal pain, diarrhea, constipation, bloating, 
flatulence, vomiting and nausea (Ebert 2012; Bengtsson 
et al. 2011). Some patients with SS and IBS are found to 
have celiac sprue (Conti et al. 2015). The current studies 
were undertaken to evaluate if patients with SS and IBS 
symptoms in our clinic population had hypersensitivi-
ties to particular foods, whether or not they met criteria 
for celiac sprue, and if elimination of the offending foods 
would alleviate their symptoms.
Methods
Ten patients were identified from the adult autoimmune 
disease clinics at SUNY at Buffalo School of Medicine 
who met the 2012 ACR criteria for the diagnosis of SS 
and complained of abdominal pain, bloating, diarrhea 
and fatigue associated with the ingestions of particular 
foods. All had been diagnosed with IBS or celiac sprue 
by gastroenterologists. In some cases, patients had iden-
tified particular foods as culprits, but in most cases not. 
The presence of fatigue and joint pain were determined 
by questioning the patients.
Determination of food hypersensitivities was per-
formed using the ImmunoCAP® system (Phadia AB, 
Uppsala, Sweden) to measure food-specific IgG. The food 
was immobilized on the solid phase and IgG antibodies 
were detected with a fluorescently labeled antibody. The 
latter detected all subclasses of IgG. The IgG scoring sys-
tem was established by the manufacturer (Viracor-IBT 
Laboratories, Lee’s Summit, MO) with a standard curve 
used to calculate the specific IgG concentrations. The 
calibrators were referenced to the International reference 
preparation for serum Ig. The assay range has a lower 
limit of quantitation of 2  μg/mL and an upper limit of 
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quantitation of 200 μg/mL for specific IgG. The assay was 
reported as positive when food-specific IgG levels were 
higher than 2 mcg/mL (Atkinson et al. 2004).
In each case, patients met with a dietician and devel-
oped a diet eliminating the foods identified by these 
assays. At the end of a 6  months period, patients 
attempted to reinstitute foods, one at a time. Symptoms 
were recorded before and during the elimination diet as 
well as with the reinstitution of the culprit foods. These 
studies were approved by the IRB, SUNY at Buffalo 
School of Medicine.
Results
The characteristics of the ten SS patients studied are 
shown in Table  1. This group consisted of 8 females 
and 2 males, age 28–63  years (mean 48.2  years). Most 
patients had SS for 2 years or less, although one patient 
had disease for 3  years, two for 5  years and one for 
18 years. The symptoms of bloating, diarrhea, joint pain 
and fatigue often preceded the diagnosis of SS. Inter-
estingly, although perhaps because of the nature of the 
autoimmune disease clinics at SUNY at Buffalo School 
of Medicine that have a large number of patients with 
metabolic muscle diseases, all of the patients were iden-
tified to have metabolic myopathies. Five patients had 
carnitine palmitoyl transferase deficiency. One patient 
had complex 2 disorder of the mitochondrial respiratory 
chain, and another had lactate dehydrogenase deficiency. 
All of these patient had their diagnosis confirmed based 
on muscle biopsies. Three additional patients had their 
mitochondrial dysfunction demonstrated by elevated lac-
tic acid at rest on several occasions, without an alterna-
tive explanation. Besides SS and metabolic disorders, two 
patients had psoriasis and three had anti-phospholipid 
antibody syndrome.
The clinical features that brought these patients to 
medical attention were abdominal pain, bloating, diar-
rhea and fatigue associated in many cases with joint pains 
involving predominantly the wrists, knees and ankles. 
Gastroenterologist had performed endoscopies and colo-
noscopies on all of these patients. One patients was diag-
nosed with celiac sprue, but still had ongoing symptoms 
after elimination of gluten. The remainder of the patients 
had been given the diagnosis of IBS. All of the patients 
had deficiencies in 25-OH Vitamin D, often with levels 
less than 20  ng/ml (Normal 30–100  ng/ml), suggesting 
some degree of malabsorption (Table 2). One patient had 
an episode of uveitis that was unexplained, but may have 
be related to gastrointestinal inflammation (Rachitskaya 
et al. 2010).
The ImmunoCAP® testing for IgG reactivity to 
foods revealed reactivities to multiple food in all cases 
(Table  2). Reactivity to wheat and dairy was present in 
all but one patient. Other common reactivities were to 
eggs, beef and corn. All of the patients had autoantibod-
ies associated with SS, ANA, RF, anti-Ro, anti-salivary 
gland protein 1 (SP1), anti-carbonic anhydrase 6 (CA6) 
and/or anti-parotid secretory protein (Kyriakidis et  al. 
2014; Shen et  al. 2012, 2014). Most of the patients had 
antibodies associated with inflammation in the gastro-
intestinal tract, five patients had anti-S. cerevesiae anti-
bodies (ASCA), one patient had atypical pANCA and 
one patient had anti-gliadin antibodies (Torok et al. 2004; 
Beniwal and Harrell 2010).
As shown in Table 3, all patients, except for two, were 
able to eliminate all the foods from their diets to which 
they had hypersensitivity. The eight patients with com-
plete elimination diets had full resolution of abdominal 
pain, bloating, diarrhea and joint pain on the restricted 
diet. The two patients with incomplete elimination diets 
Table 1 The Table summarizes demographic data in ten patients studied with SS and IBS–like symptoms
Mitochondrial dysfunction was defined as elevated lactic acid while at rest without any explanation for the elevation, such as liver failure






1 30 F 1 Psoriasis; mitochondrial dysfunction
2 28 F 2 Carnitine palmitoyl transferase deficiency
3 39 F 2 Polymyositis; carnitine palmitoyl transferase deficiency
4 50 M 2 Carnitine palmitoyl transferase deficiency
5 53 M 5 Psoriasis; APLA; mitochondrial dysfunction
6 56 F 1 Complex 2 disorder mitochondrial respiratory chain; APLA; celiac sprue
7 54 F 2 Lactate dehydrogenase deficiency
8 49 F 5 Carnitine palmitoyl transferase deficiency
9 60 F 3 Carnitine palmitoyl transferase deficiency; APLA
10 63 F 18 Mitochondrial dysfunction
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did eliminate wheat and dairy from their diets and noted 
improvement but not resolution of their abdominal 
symptoms. In all cases, symptoms returned when culprit 
foods were re-introduced. Re-introduction of food was 
done one food at a time. In most cases, ingestion of either 
wheat or dairy returned the gastrointestinal symptoms 
that had occurred before the elimination diet. Over time, 
some patients were able to re-introduce some foods with-
out symptoms, such as tomato, pork and rice.
While fatigue was a major component in the symptoms 
of all these patients, elimination diets improved but did 
not resolve it. Further improvement in fatigue came from 
addressing the underlying metabolic diseases. Patients 
with mitochondrial dysfunction from any cause received 
CoQ10, creatine, carnitine, folic acid and alpha-lipoic 
acid (Tarnopolsky 2008; Abdullah et  al. 2012; Ambrus 
2009). The patient with lactate dehydrogenase deficiency 
was treated with a diet avoiding complex carbohydrates 
and rich in simple sugars (Weinstein and Wolfsdorf 
2002).
Discussion
The current study was an observational study made on a 
group of patients with SS derived from a University auto-
immune disease clinic that also specializes in metabolic 
muscle diseases. It is therefore a very selected group of 
patients. Nonetheless, these patients presented with 
symptoms that are common to SS patients everywhere 
and often ascribed to IBS, bloating, diarrhea, joint pain 
and fatigue (Bengtsson et  al. 2011; Daniels et  al. 2011). 
Patients were identified to have various food hypersensi-
tivities by IgG reactivity to these foods. Diets eliminating 
Table 2 This table summarizes the foods to which the patients had positive food reactivities based on specific IgG Immu-
noCAP® studies
Autoantibodies were determined by ELISA assays
ASCA anti‑Saccharomyces cerevesiae antibodies, anti‑CA6 anti‑carbonic anhydrase 6, anti‑PSP anti‑parotid secretory protein, anti‑SP1 anti‑salivary gland protein 1
Patient Food hypersensitivities Autoantibodies
1 Wheat, dairy, eggs, beef, corn ASCA, ANA
2 Wheat, dairy, beef, corn, rice, tomato, carrot, broccoli, apple ASCA, ANA, anti‑SP1
3 Wheat, dairy ASCA, ANA
4 Wheat, eggs, dairy, banana, beef, rice, corn, almond Atypical pANCA, anti‑CA6, anti‑PSP
5 Wheat, soy, dairy, corn banana, egg, peanut, shrimp, almond, tomato ANA, RF
6 Wheat, eggs, dairy, banana, beef, pork, corn, rice, tomato, soy ANA, anti‑gliadin, APLA
7 Rice, almonds, eggs, banana ASCA, ANA, anti‑SP1
8 Wheat, dairy, tomato, eggs Anti‑Ro
9 Wheat, eggs, dairy, soy, corn, strawberry ASCA, ANA, anti‑Ro
10 Wheat, eggs, dairy, corn, beef Anti‑SP1
Table 3 This table summarizes the symptoms attributable to food hypersensitivities in each of the patients, their symp-
toms on their elimination diets and the foods added back that caused the initial symptoms to recur
Patient Symptoms ascribed to food hypersensi-
tivity
Symptoms remaining on food elimination Recurrence of all symptoms with food 
re-challenge
1 Bloating, diarrhea, joint pain, fatigue Mild fatigue Yes; wheat or dairy
2 Bloating, diarrhea, joint pain, fatigue All improved, but never complete food 
elimination
Yes; wheat, corn or dairy
3 Bloating, diarrhea, joint pain, fatigue Mild fatigue Yes; wheat or dairy
4 Bloating, diarrhea, joint pain, fatigue, scleritis Mild fatigue Yes; wheat, eggs, dairy or beef
5 Bloating, joint pain, fatigue Mild fatigue Yes; wheat or dairy
6 Bloating, diarrhea, joint pain, fatigue Mild fatigue Yes; dairy, corn, soy or rice; she would not try 
wheat
7 Bloating, diarrhea, joint pain, fatigue Fatigue Yes; rice, eggs or banana
8 Bloating, diarrhea, joint pain, fatigue Mild fatigue Yes; wheat or diary or eggs
9 Bloating, diarrhea, joint pain, fatigue All improved, but never complete food 
elimination
Yes; wheat or dairy
10 Bloating, diarrhea, joint pain, fatigue Mild fatigue Yes; wheat, corn or dairy
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these foods led to resolution of symptoms that recurred 
with re-introduction of the foods. Resolution of fatigue 
required attention to not only the food hypersensitivities 
but also to metabolic disorders.
The incidence of celiac sprue, or gluten hypersensitiv-
ity, is estimated to be 1 % of the population and to be pre-
sent in many patients with Sjogren’s syndrome (Rashtak 
et  al. 2009). Celiac sprue is associated with abdominal 
pain, diarrhea, bloating, arthritis, uveitis, fatigue, iron 
deficiency and various vitamin deficiencies, including 
vitamin D (McGough and Cummings 2005). It is known 
that many patients with celiac sprue to not respond to 
elimination of gluten alone. Many theories exist regard-
ing the failure of gluten elimination alone to resolve 
symptoms in these patients (Farrell and Kelly 2002).
More recently, it has been recognized that hypersen-
sitivity reactions can occur to food other than gluten. In 
fact, gastroenterologists discuss the entity of non-celiac 
sprue wheat hypersensitivity as a common entity (Bat-
tais et al. 2003). The idea that hypersensitivities to other 
foods, such as dairy, eggs and beef, giving similar symp-
toms to celiac sprue is a relatively new concept that is 
undergoing intense study (Zuo et al. 2007). Allergist stud-
ying “food allergies” recognize IgE mediated reactions to 
foods that cause immediate diarrhea, skin rash and swell-
ing upon ingestion of the foods (Kurowski and Boxer 
2008). It is being recognized more by gastroenterolo-
gists than allergists that hypersensitivities to foods cause 
delayed reactions (8–48 h after ingestion) that most com-
monly include bloating, diarrhea and fatigue (Jyonouchi 
2008; Wolfe and Aceves 2011). It is also recognized that 
any type of gastrointestinal inflammation can lead to 
secondary arthralgia/arthritis most commonly involv-
ing the wrists, knees and ankles (Holden et al. 2003). Our 
patients clearly had symptoms suggestive of food hyper-
sensitivities, with blood test demonstrating food sensitiv-
ities and resolution of symptoms with elimination diets 
that recurred with reintroduction of foods. These data 
suggest that hypersensitivity to these foods was a criti-
cal driver for these symptoms. The mechanism by which 
these food hypersensitivities caused these symptoms is 
entirely unclear, and should be the topic of future studies.
That these symptoms occurred in a population of 
patients with SS raises several interesting issues. First, it 
could be that food hypersensitivities and SS are both com-
mon entities and we happened to find patients in which 
they co-exist. This would be supported by the fact that 
many of the patients had gastrointestinal symptoms before 
the identification of SS. However, SS can frequently exist 
for several years before it is diagnosed (Akpek et al. 2015). 
Second, the SS patients may have been a unique sub-
set. It is true that all the patients had autoantibodies and 
met ACR criteria for SS, however, many lacked anti-Ro 
or anti-La antibodies. Several patients had anti-SP1 anti-
bodies. Whether anti-SP1, anti-CA6 and/or anti-PSP 
denote different subsets of SS is currently being evaluated 
in several studies (Suresh et al. 2015; Ambrus et al. 2012). 
Lastly, all of the patients in these groups of SS patients had 
underlying metabolic diseases. It is possible that the meta-
bolic diseases participated in the development of both 
the food hypersensitivities and the SS. One scenario that 
could be envisioned, and would have to be evaluated in 
future studies, is that the underlying metabolic disease led 
to increased susceptibility to infection and increased dif-
ficulty in clearing infections. Infections in the gastrointes-
tinal tract, with enteroviruses for example, would lead to 
reactivity to foods that were commonly in the diet. At the 
same time, infections in the salivary and lacrimal glands, 
with CMV or mumps for example, could initiate the events 
leading to SS. Many other scenarios can be envisioned. 
The bias of this study is that patients were selected from a 
clinic that specializes in autoimmune diseases and meta-
bolic diseases. Further studies will have to evaluate these 
issues in a broader population of SS patients.
In summary, patients selected from an academic auto-
immune disease and metabolic disease clinic identified 10 
patients with SS and IBS like symptoms that were caused 
by hypersensitivity to foods, the most common being 
wheat and dairy. Fatigue in these patients was related to 
food hypersensitivities and underlying metabolic disor-
ders. Treatment of all of these issues is necessary to help 
these patients feel better and have a better quality of life.
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